Full name
GENEME LABORATORIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
GENEME LABORATORIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. KAMPINOSKA 25, 80-180 GDAŃSK
TAX ID9571123812
Rate company:
GENEME LABORATORIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9571123812
KRS0000839974
Share capital5,000.00 zł
address
UL. KAMPINOSKA 25, 80-180 GDAŃSK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9571123812
REGON
385999353
KRS
0000839974
Legal form
limited liability company
Register Address
UL. KAMPINOSKA 25, 80-180 GDAŃSK
Date of registration in KRS
2020-05-04
Date of commencement of economic activity
2020-05-04
Act signature
GD.VII NS-REJ.KRS/22531/21/30/ADE
Pkd codes
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL47 1050 1764 1000 0090 3220 4746 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,1 | -0,2 | -0,3 | -20,8 |
EBITDA | -0,2 | -0,2 | -25,7 | |
Short time liabilities | 0,6 | 0,7 | 13,9 | |
Income tax | 0 | -∞ | ||
Equity capital | 0,1 | -0,1 | -0,3 | -356,6 |
Operating profit (EBIT) | -0,2 | -0,3 | -24,3 | |
Assets | 0,8 | 0,6 | 0,4 | -29,1 |
Net profit (loss) | 0,1 | -0,2 | -0,3 | -20,8 |
Cash | 0,2 | 0 | -77,3 | |
Net income from sale | 2,5 | 0,4 | -82,4 | |
Liabilities and provisions for liabilities | 0,6 | 0,7 | 0,7 | 12,3 |
Working assets | 0,8 | 0,6 | 0,4 | -25,2 |
Depreciation | 0 | 0 | 15,5 | |
Basic operational activity income | 0,8 | -∞ | ||
% | % | % | p.p. | |
Profitability of capital | 96,5 | 291,3 | 77,1 | -214,2 |
Equity capital to total assets | 17,6 | -12 | -77,3 | -65,3 |
Gross profit margin | 18,8 | -8,4 | -57,6 | -49,2 |
EBITDA Margin | -7,3 | -51,9 | -44,6 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 87 | 562 | 475 | |
Current financial liquidity indicator | 0.8381840586662292 | 0.558182954788208 | -0,2 | |
Net dept to EBITDA | 1.042842149734497 | -0.09275498241186142 | -1,1 |
Financial statements
01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.